We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cervical Cancer Detection Using Optical Spectroscopy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00900575
Recruitment Status : Recruiting
First Posted : May 13, 2009
Last Update Posted : April 25, 2022
Sponsor:
Information provided by (Responsible Party):
Duke University

Brief Summary:
The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.

Condition or disease Intervention/treatment Phase
Cervical Cancer Device: Optical Spectroscopy Bench-Top System Device: Portable Optical Spectrometer Device: Transvaginal colposcope Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 350 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Cervical Cancer Detection Using Optical Spectroscopy
Actual Study Start Date : May 2006
Estimated Primary Completion Date : December 31, 2022
Estimated Study Completion Date : December 31, 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cervical Cancer

Arm Intervention/treatment
Experimental: Colposcope
Patients referred for GYN procedures. Specifically, patients will be referred for Pap smear, colposcope or LEEP. The intervention for this arm is the use of the bench-top, miniature optical spectrometer or trans-vaginal colposcope
Device: Optical Spectroscopy Bench-Top System
This device is a bench-top optical spectrometer

Device: Portable Optical Spectrometer
This device is a portable optical spectrometer

Device: Transvaginal colposcope
Other Names:
  • TVDC
  • Transvaginal digital colposcope, Pocket colposcope, callascope




Primary Outcome Measures :
  1. Identification of optical signatures of cervical tissue [ Time Frame: Day of procedure (less than 10 minutes) ]
    The primary outcome of this study is the identification of the optical signatures of cervical tissue.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • undergoing colposcopy for the diagnosis of cervical cancer
  • LEEP for the treatment of cervical cancer in early stages.
  • Follow-up Pap smear in surveillance

Exclusion Criteria:

  • Women under the age of 18 (minors) will be excluded from this study.
  • patients will be excluded if she has had a recent episode of bleeding or preterm labor.
  • Subjects who are not competent to give consent will excluded

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00900575


Contacts
Layout table for location contacts
Contact: Nimmi Ramanujam, Ph.D. 919-660-5307 nimmi@duke.edu

Locations
Layout table for location information
United States, North Carolina
Duke University Medical Center Recruiting
Durham, North Carolina, United States, 27710
Principal Investigator: Nimmi Ramanujam, Ph.D.         
Sub-Investigator: John Schmitt, M.D.         
Sponsors and Collaborators
Duke University
Investigators
Layout table for investigator information
Principal Investigator: Nimmi Ramanujam, Ph.D. Duke University
Additional Information:
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Duke University
ClinicalTrials.gov Identifier: NCT00900575    
Other Study ID Numbers: Pro00008173
First Posted: May 13, 2009    Key Record Dates
Last Update Posted: April 25, 2022
Last Verified: March 2022
Keywords provided by Duke University:
cervical cancer
LEEP
colposcopy
Pap smear
Additional relevant MeSH terms:
Layout table for MeSH terms
Uterine Cervical Neoplasms
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Uterine Cervical Diseases
Uterine Diseases